MedPath

Meda Pharmaceuticals Inc.

Meda Pharmaceuticals Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:3
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

Cortifoam

Approval Date
Feb 27, 2024
FDA

EPIFOAM

Approval Date
Feb 15, 2024
FDA

ELESTRIN

Approval Date
Dec 15, 2023
FDA

Rowasa

Approval Date
Oct 31, 2023
FDA

sfRowasa

Approval Date
Oct 15, 2023
FDA

Dipentum

Approval Date
Oct 15, 2023
FDA

Depen

Approval Date
Jul 19, 2023
FDA

Soma

Approval Date
May 15, 2023
FDA

Edluar

Approval Date
Aug 15, 2022
FDA

DYMISTA

Approval Date
Aug 8, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.